Siren LLC’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.91M Sell
2,004,739
-995,261
-33% -$2.03M 0.08% 96
2026
Q1
$7.38M Hold
3,000,000
0.2% 66
2025
Q4
$11.9M Buy
3,000,000
+1,834,043
+157% +$8.12M 0.36% 49
2025
Q3
$4.41M Buy
+1,165,957
New +$3.96M 0.17% 69

Other funds holding NBP

Siren LLC's NBP Position: Q2 2026 in Review

Siren LLC reduced its NovaBridge Biosciences American Depositary Shares (NBP) stake by 33% in Q2 2026, selling an estimated $2.03M and leaving 2,004,739 shares worth $3.91M. The position accounts for 0.08% of the portfolio, ranked #96.

Siren LLC first reported a position in NBP in Q3 2025 and has held it in 4 quarters since. The position peaked at $11.9M in Q4 2025. 49 funds tracked by Wall St. Rank hold NBP as of Q2 2026.

  • Siren LLC held 2,004,739 shares of NovaBridge Biosciences American Depositary Shares worth $3.91M as of Q2 2026.
  • Siren LLC sold 995,261 NovaBridge Biosciences American Depositary Shares shares in Q2 2026, an estimated $2.03M.
  • NovaBridge Biosciences American Depositary Shares made up 0.08% of Siren LLC's portfolio in Q2 2026, its #96 holding.
  • Siren LLC first reported a position in NovaBridge Biosciences American Depositary Shares in Q3 2025 and has held it in 4 quarters since.
  • Siren LLC's NovaBridge Biosciences American Depositary Shares position peaked at $11.9M in Q4 2025.
  • 49 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2026.

Based on Siren LLC's 13F filing for Q2 2026, filed 13 Aug 2026.